Breast Cancer Imaging Market

Breast cancer disease is amongst the most widespread cancers affecting female population across developed and developing economies. As per American Cancer Society, breast cancer disease is the second-prominent cause of cancer-linked deaths in females across the world. In United States, one in every eight women acquires intrusive breast cancer throughout the course of her life expectancy. As per the articles published by American Cancer Society as well as the National Cancer Institute, in the year 2018, over and about 265,000 new patients of invasive breast cancer disease would be diagnosed among females in the US every year, with around 63,960 fresh cases of non-invasive breast cancer patients. In country like Canada, as many as approx. 26,300 women were detected with breast cancer. On an approx. average, 72 Canadian females were detected with breast cancer disease every day.

To have an edge over the competition by knowing the market dynamics and current trends of “Breast Cancer Imaging Market”, request for Sample Report here

The global market for breast cancer imaging has expanded rapidly in recent years and expected to grow at a robust rate in the coming years also. The global breast cancer imaging was estimated at USD 1,055 million in 2018, and is projected to reach USD 2,246 million by 2026, growing at a CAGR of 8.5% during 2019-2026. The key factors bolstering the growth of the market include increasing incidences of breast cancer patients, introduction of custom-made implant products, technological advancement in imaging devices, rise in prevalence of life-style related diseases and disorders and various cancer screening campaigns run by institutions. In 2019 in United States it is expected that 268,600 fresh cases of invasive cancer as well as 62,930 cases of non-invasive cancer is expected to be diagnose.

Healthcare facilities like hospitals, outpatient clinics etc. that buy such costly device systems often hinge on on third-party paymasters for reimbursements of expenses incurred in diagnosing and procedures operated with these device systems. However, it approximately takes more than two to five years for a device system to ensure reimbursement once introduced in the regional market. Because of the excessive cost of these device systems and budget limitations, healthcare facilities like hospitals etc are unwilling to spend in technologically advanced device systems.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Based on type, non-ionizing system is anticipated to lead the market during 2019–2026. Non-Ionizing type segment is expected to hold maximum share in the market during the forecast period due to minimal risk of exposure of body to radiation, more benefits accessible by breast ultrasound, the capability to distinguish between a cyst tumour and a solid mass and the recognition of blood movement through vessels.

Based on end-user, hospital segment is anticipated to lead the market during 2019–2026. Hospital segment captured the maximum revenue share in 2018 due to increasing breast cancer cases and rising global geriatric population. Diagnostic centers segment expected to grow at the highest CAGR during forecast period owing to the rising awareness regarding breast cancer and its treatment as well as increasing technological advancements in the breast cancer imaging devices.

North America held the largest share in global breast cancer imaging market in 2018 owing to increasing government and private funding on healthcare infrastructure, rising incidence of breast cancer and growing awareness of technology in breast cancer imaging devices. Asia-Pacific is expected to grow at to a faster rate during the forecast period in global breast cancer imaging market. Growing per capita income, rapidly improving healthcare infrastructure as well as supportive government measures in emerging economies such as India and China will further are the key factors which will fuel the breast cancer imaging market in the region.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Customization here

Big players are investing a lot in research & development activities. The companies are focusing on organise symposiums regarding the breast cancer and its treatment for keeping their leadership in global breast cancer imaging market. Various notable players operating in global breast cancer imaging market include Hologic Inc, GE Healthcare, Siemens, Philips, Fujifilm Holding Corporation, Aurora Imaging Technology, Canon Inc, CMR Naviscan Corporation, Dilon Technologies and SonoCine Inc among others.

The global breast cancer imaging market has been segmented on the basis of type, end user and key geographies. Based on type, the market comprises of ionizing and non-ionizing. The end user includes hospitals and diagnostic labs and key geographic areas.

For detailed scope of the “Breast Cancer Imaging Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is the breast cancer imaging market is growing worldwide? What will be the growth trend in future?
  • What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in global breast cancer imaging market?
  • What are the various types of breast cancer imaging and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Market Segmentation:

Global Breast Cancer Imaging Market By Type

• • Ionizing
  • Non-Ionizing

Global Breast Cancer Imaging Market By End User

• • Hospitals
  • Diagnostic Centers

Global Breast Cancer Imaging Market By Geography

• • North America Breast Cancer Imaging Market
    Option 1: As a part of the free 25% customization
    • North America Breast Cancer Imaging Market By Type
    • North America Breast Cancer Imaging Market By End User
    • United States of America (US) Breast Cancer Imaging Market All-Up
    • Canada Breast Cancer Imaging Market All-Up
  • Europe Breast Cancer Imaging Market
    Option 2: As a part of the free 25% customization
    • Europe Breast Cancer Imaging Market By Type
    • Europe Breast Cancer Imaging Market By End User
    • United Kingdom (UK) Breast Cancer Imaging Market All-Up
    • Germany All-Up Breast Cancer Imaging Market All-Up
    • France Breast Cancer Imaging Market All-Up
    • Spain Breast Cancer Imaging Market All-Up
    • Rest of Europe Breast Cancer Imaging Market All-Up
  • Asia-Pacific Breast Cancer Imaging Market
    Option 3: As a part of the free 25% customization
    • Asia-Pacific Breast Cancer Imaging Market By Type
    • Asia-Pacific Breast Cancer Imaging Market By End User
    • China Breast Cancer Imaging Market All-Up
    • India Breast Cancer Imaging Market All-Up
    • Japan Breast Cancer Imaging Market All-Up
    • Rest of APAC Breast Cancer Imaging Market All-Up
  • ROW Breast Cancer Imaging Market
    Option 4: As a part of the free 25% customization
    • ROW Breast Cancer Imaging Market By Type
    • ROW Breast Cancer Imaging Market By End User
    • Brazil Breast Cancer Imaging Market All-Up
    • South Africa Breast Cancer Imaging Market All-Up
    • Saudi Arabia Breast Cancer Imaging Market All-Up
    • UAE Breast Cancer Imaging Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Breast Cancer Imaging Market All-Up

Breast Cancer Imaging Leading Market Players (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Hologic Inc.
  • GE Healthcare
  • Siemens
  • Philips
  • Fujifilm Holding Corporation
  • Aurora Imaging Technology
  • Canon Inc.
  • CMR Naviscan Corporation
  • Dilon Technologies
  • SonoCine Inc.